Karleen M. Oberton serves as the Chief Financial Officer (CFO) at Hologic, Inc., a leading medical technology company focused on improving women's health and well-being. With an extensive background in finance and accounting, Oberton has played a pivotal role in steering Hologic's financial strategy and growth. She joined Hologic in 2018 and has since been instrumental in enhancing the company's financial performance and operational efficiency. Before joining Hologic, Oberton held significant leadership positions in various companies within the healthcare and medical device sectors. She was the Vice President of Finance and Treasurer at Analogic Corporation, where she managed global financial operations and strategic planning. Oberton's career also includes a tenure at Boston Scientific Corporation, where she served as the Corporate Controller, overseeing the company's financial reporting and compliance. Her diverse experience in these roles has equipped her with a deep understanding of the industry's financial landscape, enabling her to drive Hologic's fiscal success. As CFO at Hologic, Oberton is responsible for overseeing all aspects of the company's financial operations, including financial planning and analysis, accounting, tax, treasury, and investor relations. Under her leadership, Hologic has seen significant financial growth and stability, navigating through challenging market conditions with resilience and strategic foresight. Oberton's commitment to excellence and her strategic vision continue to be vital assets to Hologic as the company advances its mission to empower women's health globally.